Fragment-based design of Mycobacterium tuberculosis InhA inhibitors.

Tuberculosis (TB) remains a leading cause of mortality amongst infectious diseases worldwide. InhA, an enoyl ACP-reductase, has been the focus of numerous drug discovery efforts as this is the targ...